Benjamin Raab, MD
Dermatology · Aurora, ILNPI 1992753925
Payments from drug & device makers
Across 109 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$962
- Sun Pharmaceutical Industries Inc.$331
- Amgen$297
- Sanofi$293
- Lilly USA, LLC$162
- LEO Pharma Inc.$131
- plus $566 from 13 others
What the payments were for
- Consulting fees$60022%
- Food & beverage$2,00973%
- Education$1345%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $962 |
| Sun Pharmaceutical Industries Inc. | 12 | $331 |
| Amgen | 16 | $297 |
| Sanofi | 13 | $293 |
| Lilly USA, LLC | 10 | $162 |
| LEO Pharma Inc. | 7 | $131 |
| Biofrontera Inc. | 5 | $100 |
| E.r. Squibb & Sons, L.L.C. | 4 | $81 |
| Dermavant Sciences, Inc. | 5 | $80 |
| Organogenesis Inc. | 3 | $66 |
| Boehringer Ingelheim | 2 | $59 |
| Galderma Laboratories, L.p. | 2 | $31 |
| Pfizer | 2 | $31 |
| Mayne Pharma Commercial LLC | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Journey Medical Corporation | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Incyte Corporation | 1 | $13 |
How this compares
$2,743 in reported general payments places this provider in the 50th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 111 | $5,347 |
| Halobetasol Propionate | 45 | $2,687 |
| Ketoconazole | 107 | $1,613 |
| Fluorouracil | 20 | $1,233 |
| Alclometasone Dipropionate | 24 | $577 |
| Clobetasol Propionate | 18 | $564 |
| ValacyclovirValacyclovir Hcl | 22 | $456 |
| Cefadroxil | 56 | $422 |
| Minocycline Hcl | 14 | $230 |
| Triamcinolone Acetonide | 28 | $211 |
| Prednisone | 54 | $173 |
| Terbinafine Hcl | 19 | $121 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Aurora
- Michael BukhaloRolling Meadows$6.8M
- Stephanie MehlisSkokie$6.4M
- Ahmad AminNaperville$4.6M
- George LewittNorthbrook$4M
- Raj ChovatiyaChicago$3.7M
- Peter LioChicago$2.5M
- Paul GetzWest Dundee$2.4M
- Kyle AmberBerwyn$2.3M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.